Cargando…
Long non‐coding RNAs regulate treatment outcome in leukemia: What have we learnt recently?
Leukemia is a group of highly heterogeneous and life‐threatening blood cancers that originate from abnormal hematopoietic stem cells. Multiple treatments are approved for leukemia, including chemotherapy, targeted therapy, hematopoietic stem cell transplantation, radiation therapy, and immunotherapy...
Autores principales: | Shi, Huiping, Gao, Liang, Zhang, Weili, Jiang, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358217/ https://www.ncbi.nlm.nih.gov/pubmed/37148556 http://dx.doi.org/10.1002/cam4.6027 |
Ejemplares similares
-
Reverse-genetics studies of lncRNAs—what we have learnt and paths forward
por: Gao, Fan, et al.
Publicado: (2020) -
Zika Virus: What Have We Learnt Since the Start of the Recent Epidemic?
por: Saiz, Juan-Carlos, et al.
Publicado: (2017) -
Defining transposition: What have we learnt?
por: Roderick, Max E., et al.
Publicado: (2021) -
What have we learnt from Covid?
por: Salter, Mark Steven
Publicado: (2021) -
Treating diabetic dyslipidemia: What have we learnt from recent clinical trials?
por: Tan, Kathryn CB
Publicado: (2010)